June 19, 2017
The Federation of Pharmaceutical Manufacturers’ Associations of Japan’s (FPMAJ) committee on drug pricing affairs on June 16 issued a report, calling for creating a full-scale system to maintain drug prices for the duration of their patents. The report, which the...read more